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EFFECTS OF FLAX SUPPLEMENTATION AND A REVALOR-S IMPLANT ON CIRCULATING INSULIN-LIKE GROWTH FACTOR 1 (IGF-
1
Summary
Sixteen crossbred steers weighing 875 lb were used to evaluate the effects of a 5% ground flaxseed supplement and a combined trenbolone acetate/estradiol (TBA/E 2 ) growth promoting implant, Revalor-S ® , on both circulating insulin-like growth factor-1 (IGF-1) and local muscle IGF-1 mRNA concentrations. Steers were randomly assigned to one of four treatments: . 1) Flax/Implant, 2) No Flax/ Implant, 3) Flax/No Implant, 4) No Flax/No Implant. Serum was harvested from blood collected via jugular venipuncture on day 0 (before implantation or flax addition), 14, and 28. Muscle biopsy samples were obtained from the longissimus muscle on days 0, 14, and 28. Implanted steers had 52 and 84% higher (P<0.05) circulating IGF-1 levels than nonimplanted steers on days 14 and 28, respectively. Cattle fed diets without flax had higher levels of muscle IGF-1 mRNA than cattle fed diets with flax on day 28 (4.4-fold, P<0.01). Our data support that the administration of a combined TBA/E 2 growth promotant increases circulating IGF-1 and local muscle IGF-1 mRNA concentrations in finishing cattle. However, this increase in muscle IGF-1 mRNA appears to be attenuated by the addition of a dietary flax supplement.
Introduction
Growth promoting implants containing both trenbolone acetate (TBA) and estradiol (E 2 ) are known to increase insulin-like growth factor-1 (IGF-1) levels in circulation as well as IGF-1 mRNA levels in the muscle of finishing cattle. IGF-1 is a very important growth factor for skeletal muscle growth because it stimulates muscle cell proliferation, differentiation, and protein synthesis. Flaxseed is a source of alpha-linolenic acid, which is an omega-3 polyunsaturated fatty acid. Additions of dietary omega-3 fatty acids have been shown to increase cell membrane fluidity, which may enhance the ability of IGF-1 to bind to its receptor in muscle tissue, thus potentiating IGF-1 actions in muscle. There is potential for additive or synergistic effects on muscle growth when growth promotants that increase both circulating IGF-1 and muscle IGF-1 mRNA concentrations are used in conjunction with feedstuffs high in omega-3 fatty acids. The objective of our study was to determine how circulating IGF-1 and muscle IGF-1 mRNA levels are affected by a 5% ground flaxseed supplement and administration of a combined TBA/E 2 implant, Revalor-S.
Experimental Procedures
Sixteen crossbred steers weighing 875 lb were stratified by weight and randomly assigned to one of four treatments: 1) Flax/Implant, 2) No Flax/Implant, 3) Flax/No Implant, 4) No Flax/No Implant. Steers were allowed ad libitum access to a 92% concentrate diet supplied once daily (Table 1) . Serum was harvested from blood samples collected by jugular venipuncture on days 0 (before implantation and flax addition), 14, and 28 and were stored for subsequent analysis of circulating IGF-1. Muscle biopsy samples were obtained from the longissimus dorsi on days 0, 14, and 28 using a Bergstrom biopsy needle. Total RNA was isolated from the muscle samples, and real-time quantitative polymerase chain reaction (PCR) was used to evaluate IGF-1 gene expression.
Results and Discussion
Flax supplementation had no significant effect on circulating IGF-1 levels in finishing steers (Figure 1) . Implanted steers had 52 and 84% greater (P<0.05) circulating IGF-1 levels than their non-implanted counterparts on days 14 and 28, respectively (Figure 1 ). Cattle that were not supplemented with flax had higher (4.4 fold, P<0.01) levels of muscle IGF-1 mRNA on day 28 than those that received the flax supplement. On day 28, implanted steers had 2.4-fold higher (P<0.01) muscle IGF-1 mRNA levels than non-implanted steers (Figure 2) . Our data was consistent with other research findings and demonstrates that the administration of a TBA/E 2 growth promotant, Revalor-S, increased circulating IGF-1 and muscle IGF-1 mRNA levels in finishing cattle.
Flax supplementation had no effect on circulating IGF-1 levels, and it led to lower muscle IGF-1 mRNA levels on day 28 (Figure 2) . It is possible that the addition of flax to the diet increased the sensitivity of the muscle tissue to systemic IGF-1, which could, in turn, cause the level of muscle IGF-1 gene expression to be down-regulated. It is also possible that the alpha-linolenic acid in the flax supplement had direct effects on muscle IGF-1 gene expression. It is not possible to discern from our data whether dietary addition of flax has a direct or indirect effect on muscle IGF-1 mRNA levels. However, our data still offer useful information toward the ultimate goal of understanding how dietary additions of omega-3 fatty acids and the use of anabolic steroid implants impact muscle growth of finishing cattle. 
